SavedAdd your journal

Journals / Kırıkkale Üniversitesi Tıp Fakültesi Dergisi / 2021 / Cilt: 23 - Sayı: 1

Use of Inflammation Markers for Mortality Prediction in Intensive Care Patients

YOĞUN BAKIM HASTALARINDA İNFLAMASYON BELİRTEÇLERİNİN MORTALİTE TAHMİNİNDE KULLANIMI

Meltem AKTAY
Dilek ÖZCENGİZ
Dilek DESTEGÜL
Özlem ÖZKAN KUŞCU
Ferit KUŞCU
Pages
75–82
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study, we aimed to investigate whether C-reactive protein, procalcitonin, albumin, which are inflammatory markers can be used as predictors of mortality.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Calculating the expected mortality rates of intensive care patients is important, therefore some scores that can be used in mortality prediction have been developed.
📊
Key Findings & Data:Objective: Calculating the expected mortality rates of intensive care patients is important, therefore some scores that can be used in mortality prediction have been developed.
💡
Conclusion & Impact:In this study, we aimed to investigate whether C-reactive protein, procalcitonin, albumin, which are inflammatory markers can be used as predictors of mortality.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Yoğun Bakım · Mortalite · Prokalsitonin

Abstract

Objective: Calculating the expected mortality rates of intensive care patients is important, therefore some scores that can be used in mortality prediction have been developed. In this study, we aimed to investigate whether C-reactive protein, procalcitonin, albumin, which are inflammatory markers can be used as predictors of mortality.

Özet

Amaç: Yoğun bakım hastalarının beklenilen ölüm oranlarının hesaplanması, mevcut tıbbi durumu acil teşhis ve tedavi gerektirecek hastaların hızlıca belirlenmesi, yoğun bakımların standardizasyonu, hizmet kalitesinin değerlendirilmesi ve sağlanması açısından önemlidir. Bu nedenle mortalite tahmininde geliştirilen ölçekler kullanılmaktadır. Bu çalışmada mortalite prediktörü olabilecek inflamasyon belirteçlerinden C-reaktif protein, prokalsitonin, albümin ve beyaz küre değerlerinin mortalite tahminindeki etkinliğinin araştırılması amaçlandı.

🔖

Cite This Article

AKTAY, M., ÖZCENGİZ, D., DESTEGÜL, D., KUŞCU, Ö. Ö., KUŞCU, F. (2022). Use of Inflammation Markers for Mortality Prediction in Intensive Care Patients. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi, Cilt: 23 - Sayı: 1, 75–82. https://ajindex.com/articles/573308

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Cavalazzi R, Marik PE, Hirani A, Pachinburavan M, Vasu TS, Leiby BE. Association between time of admission to the ICU and mortality: a systematic review and metaanalysis. Chest. 2010;138(1):68-75
  2. Kara İ, Altınsoy S, Gök U, Onur A, Sasıbabıccı R. Factors effecting the mortality of patients hospitalized with nontraumatic reasons in general intensive care unit of state hospital. Yogun Bakım Derg. 2015;68(3):70-7
  3. Dasta JF, McLaughlin TP, Mody SH, Piech CT. Daily cost of an intensive care unit day: the contribution of mechanical ventilation. Crit Care Med. 2005;33(6):1266-71
  4. Detsky AS, Stricker SC, Mulley AG, Thibault GE. Prognosis, survival, and the expenditure of hospital resources for patients in an intensive-care unit. NEJM. 1981;305(12):667-72
  5. Bouch DC, Thompson JP. Severity scoring systems in the critical ill. Contin Educ Anaesth Crit Care Pain. 2008;8(5):181-5
  6. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818-29
  7. Brunkhorst FU, Heinz Z. Forycki. Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med. 1998;24(8):888-9
  8. Meisner M. Procalcitonin (PCT), A New, Innovative Infection Parameter, Biochemical and Clinical Aspects. 3rd ed. New York. Thieme Medical Publishing Group, 2000
  9. Lobo SM, Lobo FR, Bota DP, Lopes-Ferreira F, Soliman HM, Mélot C, Vincent JL. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. CHEST. 2003;123(6):2043-9
  10. Moshage HJ, Janssen JA, Franssen JH, Hafkenscheid JC, Yap SH. Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation. J Clin Invest. 1997;79(6):1635-41
  11. Reny JL, Vuagnat A, Ract C, Benoit MO, Safar M, Fagon JY. Diagnosis and follow-up of infections in intensive care patients: value of C-reactive protein compared with other clinical and biological variables. Crit Care Med. 2002;30(3):529-35
  12. Adıyaman E, Tokur ME, Bal ZM, Gökmen AN, Koca U. Anestezi yoğun bakım ünitesinde takip ve tedavi edilen travma hastaların retrospektif değerlendirilmesi. J Turc Soc Intens Care. 2019;17(3):146-53
  13. Simon L, Gauvin F, Amre DK, Saint-Lous P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39(2):206-17
  14. Goldhill DR, Sumner A. Outcome of intensive care patients in a group of British intensive care units. Crit Care Med